Senzime to Showcase Expanded TetraGraph Capabilities with Launch of TetraAnalytics at Euroanaesthesia 2026

UPPSALA, SE / ACCESS Newswire / June 5, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF), a global leader in precision-based patient monitoring, today announced the launch of TetraAnalytics™, a new data analytics platform designed to expand the value of the TetraGraph® system. TetraAnalytics generates advanced clinical and operational insights, helping hospitals align with clinical guidelines, increase utilization and further leverage the benefits of quantitative neuromuscular monitoring.